These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1482490)

  • 1. Combined childhood immunizations.
    Paradiso PR
    JAMA; 1992 Oct; 268(13):1685. PubMed ID: 1482490
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
    Miller MA; Meschievitz CK; Ballanco GA; Daum RS
    Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens.
    Lagos R; Valenzuela MT; Levine OS; Losonsky GA; Erazo A; Wasserman SS; Levine MM
    Lancet; 1998 May; 351(9114):1472-6. PubMed ID: 9605803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections.
    Schmitt HJ; Knuf M; Ortiz E; Sänger R; Uwamwezi MC; Kaufhold A
    J Pediatr; 2000 Sep; 137(3):304-12. PubMed ID: 10969252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
    Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
    P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA approval of a Haemophilus b Conjugate Vaccine combined by reconstitution with an acellular pertussis vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Nov; 45(45):993-5. PubMed ID: 9005308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hib booster dose for children ages 12-15 months reinstated.
    Mich Med; 2009; 108(5):19. PubMed ID: 19999857
    [No Abstract]   [Full Text] [Related]  

  • 8. A combined Haemophilus influenzae type B Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when coadministered with diphtheria, tetanus, acellular pertussis hepatitis B-inactivated poliovirus at 3, 5 and 11 months of age: results of an open, randomized, controlled study.
    Vesikari T; Forstén A; Desole MG; Ferrera G; Caubet M; Mesaros N; Boutriau D
    Pediatr Infect Dis J; 2013 May; 32(5):521-9. PubMed ID: 23190785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Apr; 42(15):296-8. PubMed ID: 8479415
    [No Abstract]   [Full Text] [Related]  

  • 10. Simultaneous administration of Haemophilus influenzae type b vaccine with acellular or whole-cell pertussis vaccine: effects on reactogenicity and immune responses to pertussis vaccines.
    Rennels MB; Reed GF; Decker MD; Edwards KM; Pichichero ME; Deloria MA; Englund JA; Anderson EL; Steinhoff MC; Deforest A
    Pediatrics; 1995 Sep; 96(3 Pt 2):576-9. PubMed ID: 7659479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From the Centers for Disease Control and Prevention. Recommended childhood immunization schedule--United States, 1997.
    JAMA; 1997 Feb; 277(5):371-2. PubMed ID: 9010160
    [No Abstract]   [Full Text] [Related]  

  • 12. From the Centers for Disease Control and Prevention. FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children.
    JAMA; 1993 May; 269(18):2359. PubMed ID: 8479054
    [No Abstract]   [Full Text] [Related]  

  • 13. Expanded programme on immunization (EPI). Immunization coverage monitoring.
    Wkly Epidemiol Rec; 1995 Jul; 70(30):213-5. PubMed ID: 7669524
    [No Abstract]   [Full Text] [Related]  

  • 14. Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children.
    CMAJ; 1993 Jan; 148(2):199-214. PubMed ID: 8452591
    [No Abstract]   [Full Text] [Related]  

  • 15. From the Centers for Disease Control and Prevention. FDA approval of a haemophilus b conjugate vaccine combined by reconstitution with an acellular pertussis vaccine.
    JAMA; 1997 Jan; 277(1):13. PubMed ID: 8980198
    [No Abstract]   [Full Text] [Related]  

  • 16. From the Centers for Disease Control and Prevention. Recommended childhood immunization schedule--United States, July-December 1996.
    JAMA; 1996 Sep; 276(10):775-6. PubMed ID: 8769579
    [No Abstract]   [Full Text] [Related]  

  • 17. Supplementary statement on newly licensed Haemophilus influenzae type B (Hib) conjugate vaccines in combination with other vaccines recommended for infants.
    CMAJ; 1995 Feb; 152(4):527-32. PubMed ID: 7859201
    [No Abstract]   [Full Text] [Related]  

  • 18. Food and Drug Administration approval of use of Haemophilus influenzae type b conjugate vaccine reconstituted with diphtheria-tetanus-pertussis vaccine for infants and children.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Dec; 42(49):964-5. PubMed ID: 8246862
    [No Abstract]   [Full Text] [Related]  

  • 19. American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: recommendations for immunization with recently and previously licensed vaccines.
    Pediatrics; 1993 Sep; 92(3):480-8. PubMed ID: 8361814
    [No Abstract]   [Full Text] [Related]  

  • 20. National Advisory Committee on Immunization (NACI). Supplementary statement on newly licensed Haemophilus influenzae type B (HIB) conjugate vaccines in combination with other vaccines recommended for infants.
    Can Commun Dis Rep; 1994 Sep; 20(18):157-60. PubMed ID: 7994285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.